These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 29363426)

  • 1. A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.
    Guo WF; Zhang SW; Shi QQ; Zhang CM; Zeng T; Chen L
    BMC Genomics; 2018 Jan; 19(Suppl 1):924. PubMed ID: 29363426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the number of driver nodes for controlling a Boolean network when the targets are restricted to attractors.
    Hou W; Ruan P; Ching WK; Akutsu T
    J Theor Biol; 2019 Feb; 463():1-11. PubMed ID: 30543810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
    Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
    J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target controllability with minimal mediators in complex biological networks.
    Ebrahimi A; Nowzari-Dalini A; Jalili M; Masoudi-Nejad A
    Genomics; 2020 Nov; 112(6):4938-4944. PubMed ID: 32905831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network output controllability-based method for drug target identification.
    Wu L; Shen Y; Li M; Wu FX
    IEEE Trans Nanobioscience; 2015 Mar; 14(2):184-91. PubMed ID: 25643411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Boolean modeling of biological networks applied to systems pharmacology.
    Irurzun-Arana I; Pastor JM; Trocóniz IF; Gómez-Mantilla JD
    Bioinformatics; 2017 Apr; 33(7):1040-1048. PubMed ID: 28073755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drivergene.net: A Cytoscape app for the identification of driver nodes of large-scale complex networks and case studies in discovery of drug target genes.
    Pham DT; Tran TD
    Comput Biol Med; 2024 Sep; 179():108888. PubMed ID: 39047507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A constrained evolutionary computation method for detecting controlling regions of cortical networks.
    Tang Y; Wang Z; Gao H; Swift S; Kurths J
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1569-81. PubMed ID: 23221081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological Network Inference and analysis using SEBINI and CABIN.
    Taylor R; Singhal M
    Methods Mol Biol; 2009; 541():551-76. PubMed ID: 19381531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controllability in cancer metabolic networks according to drug targets as driver nodes.
    Asgari Y; Salehzadeh-Yazdi A; Schreiber F; Masoudi-Nejad A
    PLoS One; 2013; 8(11):e79397. PubMed ID: 24282504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering driver nodes in chronic kidney disease-related networks using Trader as a newly developed algorithm.
    Masoudi-Sobhanzadeh Y; Gholaminejad A; Gheisari Y; Roointan A
    Comput Biol Med; 2022 Sep; 148():105892. PubMed ID: 35932730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining minimum set of driver nodes in protein-protein interaction networks.
    Zhang XF; Ou-Yang L; Zhu Y; Wu MY; Dai DQ
    BMC Bioinformatics; 2015 May; 16():146. PubMed ID: 25947063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of multilayer biological networks and applied to target identification of complex diseases.
    Zheng W; Wang D; Zou X
    BMC Bioinformatics; 2019 May; 20(1):271. PubMed ID: 31138124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CytoCtrlAnalyser: a Cytoscape app for biomolecular network controllability analysis.
    Wu L; Li M; Wang J; Wu FX
    Bioinformatics; 2018 Apr; 34(8):1428-1430. PubMed ID: 29186337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression complex networks: synthesis, identification, and analysis.
    Lopes FM; Cesar RM; Costa Lda F
    J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of complex signaling networks to a representative kernel.
    Kim JR; Kim J; Kwon YK; Lee HY; Heslop-Harrison P; Cho KH
    Sci Signal; 2011 May; 4(175):ra35. PubMed ID: 21632468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.